Cargando…

The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation

BACKGROUND: Radiotherapy is an integral part of breast cancer treatment. Immune activating properties of especially hypofractionated irradiation are in the spotlight of clinicians, besides the well-known effects of radiotherapy on cell cycle and the reduction of the clonogenic potential of tumor cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kötter, Bernhard, Frey, Benjamin, Winderl, Markus, Rubner, Yvonne, Scheithauer, Heike, Sieber, Renate, Fietkau, Rainer, Gaipl, Udo S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573696/
https://www.ncbi.nlm.nih.gov/pubmed/26383236
http://dx.doi.org/10.1186/s13014-015-0506-5
_version_ 1782390512769040384
author Kötter, Bernhard
Frey, Benjamin
Winderl, Markus
Rubner, Yvonne
Scheithauer, Heike
Sieber, Renate
Fietkau, Rainer
Gaipl, Udo S.
author_facet Kötter, Bernhard
Frey, Benjamin
Winderl, Markus
Rubner, Yvonne
Scheithauer, Heike
Sieber, Renate
Fietkau, Rainer
Gaipl, Udo S.
author_sort Kötter, Bernhard
collection PubMed
description BACKGROUND: Radiotherapy is an integral part of breast cancer treatment. Immune activating properties of especially hypofractionated irradiation are in the spotlight of clinicians, besides the well-known effects of radiotherapy on cell cycle and the reduction of the clonogenic potential of tumor cells. Especially combination of radiotherapy with further immune stimulation induces immune-mediated anti-tumor responses. We therefore examined whether hypofractionated irradiation alone or in combination with hyperthermia as immune stimulants is capable of inducing breast cancer cells with immunogenic potential. METHODS: Clonogenic assay, AnnexinA5-FITC/Propidium iodide assay and ELISA analyses of heat shock protein 70 and high mobility group box 1 protein were applied to characterize colony forming capability, cell death induction, cell death forms and release of danger signals by breast cancer cells in response to hypofractionated radiation (4x4Gy, 6x3Gy) alone and in combination with hyperthermia (41.5 °C for 1 h). Caspase-3 deficient, hormone receptor positive, p53 wild type MCF-7 and caspase-3 intact, hormone receptor negative, p53 mutated MDA-MB231 breast cancer cells, the latter in absence or presence of the pan-caspase inhibitor zVAD-fmk, were used. Supernatants of the treated tumor cells were analyzed for their potential to alter the surface expression of activation markers on human-monocyte-derived dendritic cells. RESULTS: Irradiation reduced the clonogenicity of caspase deficient MCF-7 cells more than of MDA-B231 cells. In contrast, higher amounts of apoptotic and necrotic cells were induced in MDA-B231 cells after single irradiation with 4Gy, 10Gy, or 20Gy or after hypofractionated irradiation with 4x4Gy or 6x3Gy. MDA-B231 cells consecutively released higher amounts of Hsp70 and HMGB1 after hypofractionated irradiation. However, only the release of Hsp70 was further increased by hyperthermia. Both, apoptosis induction and release of the danger signals, was dependent on caspase-3. Only supernatants of MDA-B231 cells after hypofractionated irradiation resulted in slight changes of activation markers on dendritic cells; especially that of CD86 was upregulated and HT did not further impact on it. CONCLUSIONS: Hypofractionated irradiation is the main stimulus for cell death induction and consecutive dendritic cell activation in caspase proficient breast cancer cells. For the assessment of radiosensitivity and immunological effects of radio- and immunotherapies the readout system is crucial. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-015-0506-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4573696
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45736962015-09-19 The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation Kötter, Bernhard Frey, Benjamin Winderl, Markus Rubner, Yvonne Scheithauer, Heike Sieber, Renate Fietkau, Rainer Gaipl, Udo S. Radiat Oncol Research BACKGROUND: Radiotherapy is an integral part of breast cancer treatment. Immune activating properties of especially hypofractionated irradiation are in the spotlight of clinicians, besides the well-known effects of radiotherapy on cell cycle and the reduction of the clonogenic potential of tumor cells. Especially combination of radiotherapy with further immune stimulation induces immune-mediated anti-tumor responses. We therefore examined whether hypofractionated irradiation alone or in combination with hyperthermia as immune stimulants is capable of inducing breast cancer cells with immunogenic potential. METHODS: Clonogenic assay, AnnexinA5-FITC/Propidium iodide assay and ELISA analyses of heat shock protein 70 and high mobility group box 1 protein were applied to characterize colony forming capability, cell death induction, cell death forms and release of danger signals by breast cancer cells in response to hypofractionated radiation (4x4Gy, 6x3Gy) alone and in combination with hyperthermia (41.5 °C for 1 h). Caspase-3 deficient, hormone receptor positive, p53 wild type MCF-7 and caspase-3 intact, hormone receptor negative, p53 mutated MDA-MB231 breast cancer cells, the latter in absence or presence of the pan-caspase inhibitor zVAD-fmk, were used. Supernatants of the treated tumor cells were analyzed for their potential to alter the surface expression of activation markers on human-monocyte-derived dendritic cells. RESULTS: Irradiation reduced the clonogenicity of caspase deficient MCF-7 cells more than of MDA-B231 cells. In contrast, higher amounts of apoptotic and necrotic cells were induced in MDA-B231 cells after single irradiation with 4Gy, 10Gy, or 20Gy or after hypofractionated irradiation with 4x4Gy or 6x3Gy. MDA-B231 cells consecutively released higher amounts of Hsp70 and HMGB1 after hypofractionated irradiation. However, only the release of Hsp70 was further increased by hyperthermia. Both, apoptosis induction and release of the danger signals, was dependent on caspase-3. Only supernatants of MDA-B231 cells after hypofractionated irradiation resulted in slight changes of activation markers on dendritic cells; especially that of CD86 was upregulated and HT did not further impact on it. CONCLUSIONS: Hypofractionated irradiation is the main stimulus for cell death induction and consecutive dendritic cell activation in caspase proficient breast cancer cells. For the assessment of radiosensitivity and immunological effects of radio- and immunotherapies the readout system is crucial. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-015-0506-5) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-17 /pmc/articles/PMC4573696/ /pubmed/26383236 http://dx.doi.org/10.1186/s13014-015-0506-5 Text en © Kötter et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kötter, Bernhard
Frey, Benjamin
Winderl, Markus
Rubner, Yvonne
Scheithauer, Heike
Sieber, Renate
Fietkau, Rainer
Gaipl, Udo S.
The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
title The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
title_full The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
title_fullStr The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
title_full_unstemmed The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
title_short The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
title_sort in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573696/
https://www.ncbi.nlm.nih.gov/pubmed/26383236
http://dx.doi.org/10.1186/s13014-015-0506-5
work_keys_str_mv AT kotterbernhard theinvitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT freybenjamin theinvitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT winderlmarkus theinvitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT rubneryvonne theinvitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT scheithauerheike theinvitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT sieberrenate theinvitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT fietkaurainer theinvitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT gaipludos theinvitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT kotterbernhard invitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT freybenjamin invitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT winderlmarkus invitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT rubneryvonne invitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT scheithauerheike invitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT sieberrenate invitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT fietkaurainer invitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation
AT gaipludos invitroimmunogenicpotentialofcaspase3proficientbreastcancercellswithbasallowimmunogenicityisincreasedbyhypofractionatedirradiation